CH567029A5 - - Google Patents

Info

Publication number
CH567029A5
CH567029A5 CH1514674A CH1514674A CH567029A5 CH 567029 A5 CH567029 A5 CH 567029A5 CH 1514674 A CH1514674 A CH 1514674A CH 1514674 A CH1514674 A CH 1514674A CH 567029 A5 CH567029 A5 CH 567029A5
Authority
CH
Switzerland
Application number
CH1514674A
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691959403 external-priority patent/DE1959403A1/de
Priority claimed from DE19702050815 external-priority patent/DE2050815A1/de
Priority claimed from DE19702050814 external-priority patent/DE2050814A1/de
Priority claimed from DE19702050816 external-priority patent/DE2050816A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of CH567029A5 publication Critical patent/CH567029A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CH1514674A 1969-11-26 1970-11-23 CH567029A5 (h)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19691959403 DE1959403A1 (de) 1969-11-26 1969-11-26 Neue 2-(5-Nitro-2-furyl)-thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
DE19702050815 DE2050815A1 (de) 1970-10-16 1970-10-16 Neue 2-(5-Nitro-2-furyl)-thieno eckige Klammer auf 3,2-d eckige Klammer zu pyrimidine
DE19702050814 DE2050814A1 (de) 1970-10-16 1970-10-16 Neue Verfahren zur Herstellung von 2-(5-Nitro-2-furyl)-thieno eckige Klammer auf 3,2-d eckige Klammer zu pyrimidinen
DE19702050816 DE2050816A1 (de) 1970-10-16 1970-10-16 Neue 2-(Nitro-2-furyl>thieno eckige Klammer auf 3,2-d eckige Klammer zu pyrimidine

Publications (1)

Publication Number Publication Date
CH567029A5 true CH567029A5 (h) 1975-09-30

Family

ID=27430978

Family Applications (3)

Application Number Title Priority Date Filing Date
CH1514674A CH567029A5 (h) 1969-11-26 1970-11-23
CH1731270A CH559210A5 (h) 1969-11-26 1970-11-23
CH1514974A CH568324A5 (h) 1969-11-26 1970-11-23

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH1731270A CH559210A5 (h) 1969-11-26 1970-11-23
CH1514974A CH568324A5 (h) 1969-11-26 1970-11-23

Country Status (13)

Country Link
US (1) US3661908A (h)
BE (1) BE759493A (h)
BG (2) BG17800A3 (h)
CA (1) CA926865A (h)
CH (3) CH567029A5 (h)
DK (1) DK128781B (h)
FR (1) FR2073416B1 (h)
GB (1) GB1321316A (h)
IE (1) IE34765B1 (h)
IL (1) IL35729A (h)
NL (1) NL7017210A (h)
NO (1) NO129954B (h)
SE (1) SE377938B (h)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932642A (en) * 1971-04-10 1976-01-13 Boehringer Ingelheim Gmbh Biocidal compositions containing a 2- (5'-nitro-2'-furyl)-thieno(2,3-d) pyrimidine and methods of use
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
US20040138238A1 (en) * 2002-08-08 2004-07-15 Dhanoa Dale S. Substituted aminopyrimidine compounds as neurokinin antagonists
GB0423653D0 (en) * 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
JP5546240B2 (ja) 2006-04-26 2014-07-09 ジェネンテック， インコーポレイテッド 医薬化合物
JP5291616B2 (ja) * 2006-04-26 2013-09-18 ジェネンテック， インコーポレイテッド ホスホイノシチド３−キナーゼ抑制剤化合物およびその使用方法
DK2024372T3 (da) 2006-04-26 2010-09-20 Hoffmann La Roche Thieno[3,2-d]pyrimidin-derivat, der er egnet som P13K inhibitor
CL2007003523A1 (es) * 2006-12-07 2008-08-22 Piramed Ltd Genentech Inc Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer
AR064155A1 (es) 2006-12-07 2009-03-18 Piramed Ltd Compuestos de inhibidores de fosfoinositido-3 quinasa y metodos de uso
JP5539190B2 (ja) * 2007-06-12 2014-07-02 エフ．ホフマン−ラ ロシュ アーゲー チアゾロピリミジン類及びホスファチジルイノシトール−３キナーゼのインヒビターとしてのそれらの使用
WO2009042607A1 (en) 2007-09-24 2009-04-02 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
JP5348725B2 (ja) * 2007-10-25 2013-11-20 ジェネンテック， インコーポレイテッド チエノピリミジン化合物の製造方法
GB0721095D0 (en) * 2007-10-26 2007-12-05 Piramed Ltd Pharmaceutical compounds
EP2405916B1 (en) 2009-03-12 2018-02-07 Genentech, Inc. Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
EP2451811A1 (en) * 2009-05-27 2012-05-16 F. Hoffmann-La Roche AG Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
BRPI1009022A2 (pt) 2009-05-27 2016-03-08 Hoffmann La Roche "composto, composição farmacêutica, processo para produzir uma composição farmacêutica, uso de um composto, método para tratamento de uma doença ou transtorno e kit"
NZ599939A (en) * 2009-10-12 2014-02-28 Hoffmann La Roche Combinations of a pi3k inhibitor and a mek inhibitor
BR112012026470A2 (pt) 2010-04-16 2016-08-09 Genentech Inc método para prever a sensibilidade de crescimento de células tumorais e para tratar um tumor em um paciente
WO2012088254A1 (en) 2010-12-22 2012-06-28 Genentech, Inc. Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
EP2959014B1 (en) 2013-02-25 2019-11-13 Genentech, Inc. Methods and compositions for detecting and treating drug resistant akt mutant

Also Published As

Publication number Publication date
CH559210A5 (h) 1975-02-28
FR2073416B1 (h) 1975-04-18
BE759493A (fr) 1971-05-25
FR2073416A1 (h) 1971-10-01
BG17799A3 (bg) 1973-12-25
IL35729A0 (en) 1971-01-28
US3661908A (en) 1972-05-09
IL35729A (en) 1974-01-14
CH568324A5 (h) 1975-10-31
IE34765L (en) 1971-05-26
SE377938B (h) 1975-08-04
NO129954B (h) 1974-06-17
GB1321316A (en) 1973-06-27
BG17800A3 (bg) 1973-12-25
DK128781B (da) 1974-07-01
CA926865A (en) 1973-05-22
NL7017210A (h) 1971-05-28
IE34765B1 (en) 1975-08-06

Similar Documents

Publication Publication Date Title
AU2270770A (h)
FR2073416B1 (h)
AU429630B2 (h)
CS153537B2 (h)
AU2355770A (h)
AU442375B2 (h)
AU427401B2 (h)
AU438128B2 (h)
AU442554B2 (h)
AU442535B2 (h)
AU442463B2 (h)
AU428129B2 (h)
AU428074B2 (h)
AU442357B2 (h)
AU442322B2 (h)
AU442380B2 (h)
AU428131B2 (h)
AU425297B2 (h)
AU442285B2 (h)
AU417208B2 (h)
AU414607B2 (h)
AU410358B2 (h)
CS151220B1 (h)
CS152527B1 (h)
CS149941B2 (h)

Legal Events

Date Code Title Description
PL Patent ceased